Literature DB >> 6542166

Treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photocoagulation.

S M Shapshay, P Oliver.   

Abstract

Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) is an inherited abnormality of the vasculature characterized by abnormal subepidermal vessels. Frequent, sometimes severe, epistaxis often requiring blood transfusions is present in most patients. Septal dermatoplasty and estrogen have proved to be the most successful therapies. However, the frequency of failure in treatment has stimulated a search for an alternative therapy. The Nd-YAG laser was used at low-power settings (20-25 W) to treat 6 patients with hereditary hemorrhagic telangiectasia, all of whom had been treated previously using other modalities. Laser photocoagulation diminished the frequency and severity of hemorrhage in 5 of 6 patients without complications (6 to 9 month follow-up period). The Nd-YAG laser may be used repeatedly when new accessible lesions arise, and it appears to be a useful therapeutic option for this disease that is difficult to treat.

Entities:  

Mesh:

Year:  1984        PMID: 6542166

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Basel Al Kadah; George Papaspyrou; Mathias Schneider; Bernhard Schick
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-23       Impact factor: 2.503

3.  Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).

Authors:  Kornelia E C Wirsching; Frank Haubner; Thomas S Kühnel
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-01-09       Impact factor: 2.503

Review 4.  Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.

Authors:  Arash Abiri; Khodayar Goshtasbi; Marlon Maducdoc; Ronald Sahyouni; Marilene B Wang; Edward C Kuan
Journal:  Lasers Surg Med       Date:  2019-08-22       Impact factor: 4.025

5.  Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic.

Authors:  Yuchen Jiang; Simon C Dennis; Mark P Brewin
Journal:  Lasers Med Sci       Date:  2022-05-30       Impact factor: 2.555

6.  Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm).

Authors:  A Werner; W Bäumler; S Zietz; T Kühnel; U Hohenleutner; M Landthaler
Journal:  Lasers Med Sci       Date:  2007-11-13       Impact factor: 3.161

Review 7.  Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.

Authors:  M E Begbie; G M F Wallace; C L Shovlin
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

8.  Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point of View.

Authors:  Kornelia E C Wirsching; Thomas S Kühnel
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.